US Patent Issued to Regeneron Pharmaceuticals on Jan. 20 for "IL2-based therapeutics and methods of use thereof" (New York Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,851, issued on Jan. 20, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"IL2-based therapeutics and methods of use thereof" was invented by Jiaxi Wu (Elmsford, N.Y.), Nicolin Bloch (Ossining, N.Y.), Tong Zhang (New Rochelle, N.Y.), Chia-Yang Lin (Scarsdale, N.Y.), Samuel Davis (New York), Eric Smith (New York) and Erica Ullman (Yorktown Heights, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a fusion protein comprising an antigen-binding moiety that binds specifically to human PD-1 and an IL2 moiety, and methods of use thereof."

The patent was filed on June 13, 2022, under Application No. 17/...